Transplantomics and biomarkers in organ transplantation: A report from the first international conference

Transplantation

Volumn 91, Issue 4, 2011, Pages 379-382

  Sarwal, Minnie M ^a   Benjamin, Jacqueline ^a   Butte, Atul J ^a   Davis, Mark M ^a   Wood, Kathryn ^a   Chapman, Jeremy ^b  

^a STANFORD UNIVERSITY   (United States)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

BIOMICS; CONFERENCE PAPER; GENETIC ASSOCIATION; GENOMICS; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; INFORMATION SCIENCE; METABOLITE; METABOLOMICS; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PATIENT CARE; PRIORITY JOURNAL; PROTEOMICS; TRANSPLANTIOMICS;

BIOLOGICAL MARKERS; GENOMICS; GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; ORGAN TRANSPLANTATION; PROTEOMICS; RISK FACTORS; TRANSPLANTATION TOLERANCE;

EID: 79951681784     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182105fb8     Document Type: Conference Paper

References (20)

1. Zerhouni EA. Translational and clinical science-Time for a new vision. N Engl J Med 2005; 353: 1621.
2. Chen R, Sigdel TK, Li L, et al. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol 2010; 6: e1000940.
3. Einecke G, Reeve J, Sis B, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010; 120: 1862.
4. Varagunam M, Yaqoob MM, Dohler B, et al. C3 polymorphisms and allograft outcome in renal transplantation. NEnglJMed 2009; 360:874.
5. Shen-Orr SS, Tibshirani R, Khatri P, et al. Cell type-specific gene expression differences in complex tissues. Nat Methods 2010; 7: 287.
6. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
7. Wang E, Worschech A, Marincola FM. The immunologic constant of rejection. Trends Immunol 2008; 29: 256.
8. Naesens M, Kambham N, Concepcion W, et al. The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant 2007; 7: 2504.
9. Naesens M, Lerut E, Damme BV, et al. Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. Am J Transplant 2007; 7: 2114.
10. Mas VR, Archer KJ, Scian M, et al. Molecular pathways involved in loss of graft function in kidney transplant recipients. Expert Rev Mol Diagn 2010; 10: 269.
11. Patel MR, Chang YF, Chen IY, et al. Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects. Cancer Res 2010; 70: 10141.
12. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009; 106: 5330.
13. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: Small RNAs with big effects. Transplantation 2010; 90: 105.
14. Martinez-Llordella M, Lozano JJ, Puig-Pey I, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008; 118: 2845.
15. Bharat A, Saini D, Steward N, et al. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg 2010; 90: 1094.
16. Zhang Q, Reed EF. Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol 2010; 22: 682.
17. Li L, Wadia P, Chen R, et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 2009; 106:4148.
18. Mootha VK, Lepage P, Miller K, et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 2003; 100: 605.
19. Radu CG, Shu CJ, Nair-Gill E, et al. Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog. Nat Med 2008; 14: 783.
20. Champion CI, Kickhoefer VA, Liu G, et al. A vault nanoparticle vaccine induces protective mucosal immunity. PLoS One 2009; 4: e5409.